Δ9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-γ IL-12, and IL-12 receptor β2 responses to Legionella pneumophila infection

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6461-6466

  Klein, Thomas W ^a,b   Newton, Catherine A ^b   Nakachi, Noryia ^b   Friedman, Herman ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 4; MESSENGER RNA; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE DEFICIENCY; KNOCKOUT MOUSE; LEGIONELLA PNEUMOPHILA; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 0034660138     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6461     Document Type: Article

References (59)

1. Razdan, R. K. 1986. Structure-activity relationships in cannabinoids. Pharmacol. Rev. 38:75.
2. Mechoulam, R., L. Hanus, and B. R. Martin. 1994. Search for endogenous ligands of the cannabinoid receptor. Biochem. Pharmacol. 48:1537.
3. Howlett, A. C. 1995. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:607.
4. Felder, C., and M. Glass. 1998. Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 38:179.
5. Klein, T., C. Newton, and H. Friedman. 1998. Cannabinoid receptors and immunity. Immunol. Today 19:373.
6. Newton, C. A., R. Widen, H. Friedman, and T. W. Klein. 1995. Lymphocyte subset changes following primary and secondary infection of mice with Legionella pneumophila. Immunol. Infect. Dis. 5:18.
7. Klein, T., C. Newton, Y. Yamamoto, and H. Friedman. 1999. Immune responses to Legionella. In Opportunistic Intracellular Bacteria and Immunity. L. Paradise, H. Friedman, and M. Bendinelli, eds. Plenum Press, New York, p. 149.
8. 9-tetrahydrocannabinol injection. Infect. Immun. 62:4015.
9. Kaplan, M., and M. Grusby. 1998. Regulation of T helper cell differentiation by STAT molecules. J. Leukocyte Biol. 64:2.
10. Yamamoto, Y., T. W. Klein, K. Brown, and H. Friedman. 1992. Differential morphologic and metabolic alterations in permissive versus nonpermissive murine macrophages infected with Legionella pneumophila. Infect. Immun. 60:3231.
11. Noben-Trauth, N., G. Kohler, K. Burki, and B. Ledermann. 1996. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5:487.
12. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 160:16.
13. James, S. P. 1994. Detection of cytokine mRNA expression by PCR. In Current Protocols in Immunology, Vol. 2. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 10.23.1.
14. Reiner, S., and R. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
15. Daugelat, S., and S. H. E. Kaufmann. 1996. Role of Th1 and Th2 cells in bacterial infections. Chem. Immunol. 63:66.
16. Tateda, K., T. Matsumoto, Y. Ishii, N. Furuya, A. Ohno, S. Miyazaki, and K. Yamaguchi. 1998. Seram cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines. Clin. Diag. Lab. Immunol. 5:401.
17. Hsieh, C.-S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
18. Seder, R. A., R. Gazzinelli, A. Sher, and W. E. Paul. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
19. Kopf, M., G. Le Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine respones. Nature 362:245.
20. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
21. Wu, C.-Y., J. Ferrante, M. K. Gately, and J. Magram. 1997. Characterization of IL-12 receptor β1 chain (IL-12Rβ1)-deficient mice. J. Immunol. 159:1658.
22. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
23. Rinaldi-Carmona, M., F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Neliat, D. Caput, et al. 1994. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:240.
24. Rinaldi-Carmona, M., F. Barth, J. Millan, J.-M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, et al. 1998. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharm. Exp. Ther. 284:644.
25. 9-tetrahydrocannabinol-induced catalepsy in mice. Pharm. Biochem. Behavior 50:141.
26. Klein, T., H. Friedman, and S. Specter. 1998. Marijuana, immunity and infection. J. Neuroimmunol. 83:102.
27. Joy, J. E., S. J. Watson, and J. A. Benson. 1999. Marijuana and Medicine: Assessing the Science Base. National Academy Press, Washington, D.C.
28. Emoto, Y., M. Emoto, and S. H. E. Kaufmann. 1997. Transient control of interleukin-4-producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12. Infect. Immun. 65:5003.
29. Susa, M., B. Ticac, T. Rukavina, M. Doric, and R. Marre. 1998. Legionella pneumophila infection in intratracheally inoculated T cell-depleted or -nondepleted A/J mice. J. Immunol. 160:316.
30. Kaufmann, S. H. E., M. Emoto, G. Szalay, J. Barsig, and I. E. A. Flesch. 1997. Interleukin-4 and listeriosis. Immunol. Rev. 158:95.
31. Oriss, T. B., S. A. McCarthy, M. A. K. Campana, and P. A. Morel. 1999. Evidence of positive cross-regulation on Th1 by Th2 and antigen-presenting cells: effects on Th1 induced by IL-4 and IL-12. J. Immunol. 162:1999.
32. Lingnau, K., P. Hoehn, S. Kerdine, S. Koelsch, C. Neudoerfl, N. Palm, E. Ruede, and E. Schmitt. 1998. IL-4 in combination with TGF-β favors an alternative pathway of Th1 development independent of IL-12. J. Immunol. 161:4710.
33. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y.-J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
34. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379: 343.
35. Stern, A. S., U. Gubler, D. H. Presky, and J. Magram. 1997. Structural and functional aspects of the IL-12 receptor complex. Chem. Immunol. 68:23.
36. Felder, C. C., J. S. Veluz, H. L. Williams, E. M. Briley, and L. A. Matsuda. 1992. Cannabinoid agonists stimulate both receptor-and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharm. 42:838.
37. Makriyannis, A., and R. S. Rapaka. 1990. The molecular basis of cannabinoid activity. Life Sci. 47:2173.
38. Herkenham, M., A. B. Lynn, M. D. Little, M. R. Johnson, L. S. Melvin, B. R. DeCosta, and K. C. Rice. 1990. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87:1932.
39. Amaral, D. G., and M. P. Witter. 1995. Hippocampal formation. In The Rat Nervous System. G. Paxinos, ed. Academic Press, San Diego, p. 443.
40. Weigent, D. A., and J. E. Blalock. 1997. Production of peptide hormones and neurotransmitters by the immune system. Chem. Immunol. 69:1.
41. Weidenfeld, J., S. Feldman, and R. Mechoulam. 1994. Effect of brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinol. 59:110.
42. Wirguin, I., R. Mechoulam, A. Breuer, E. Schezen. J. Weidenfeld, and T. Brenner. 1994. Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacol. 28:209.
43. Almawi, W. Y., and N. Irani-Hakime. 1998. The antiproliferative effect of glucocorticoids: is it related to induction of TGF-β? Nephrol. Dial. Transplant. 13:2450.
44. Bebo, B. F., J. C. Schuster, A. A. Vandenbark, and H. Offner. 1999. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162:35.
45. Visser, J., A. van Boxel-Dezaire, D. Methorst, T. Brunt, E. R. de Kloet, and L. Nagelkerken. 1998. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 91:4255.
46. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161:2723.
47. Howlett, A. C., and R. M. Fleming. 1984. Cannabinoid inhibition of adenylate cyclase: pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26:532.
48. 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression. Life Sci. 51:PL25.
49. Felder, C. C., K. E. Joyce, E. M. Briley, M. Glass, K. P. Mackie, K. J. Fahey, G. J. Cullinan, D. C. Hunden, D. W. Johnson, M. O. Chaney, et al. 1998. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J. Pharm. Exp. Ther. 284:291.
50. Bonhaus, D. W., L. K. Chang, J. Kwan, and G. R. Martin. 1998. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. J. Pharm. Exp. Ther. 287: 884.
51. Panina-Bordignon, P., D. Mazzeo, P. Di Lucia, D. D'Ambrosio, R. Lang, L. Fabbri, C. Self, and F. Sinigaglia. 1997. β2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100:1513.
52. van der Pouw Kraan, T. C. T. M., A. Snijders, L. C. M. Boeije, E. R. de Groot, A. E. Alewijnse, R. Leurs, and L. A. Aarden. 1998. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J. Clin. Invest. 102:1866.
53. Elenkov, I. J., E. Webster, D. A. Papanicolaou, T. A. Fleisher, G. P. Chrousos, and R. L. Wilder. 1998. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161:2586.
54. Sengupta, T. K., E. M. Schmitt, and L. B. Ivashkiv. 1996. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc. Natl. Acad. Sci. USA 93:9499.
55. Borger, P., H. F. Kauffman, D. S. Postma, and E. Vellenga. 1996. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 87:691.
56. 1-tetrahydrocannabinol-induced catalepsy in mice. Mol. Pharmacol. 35:6.
57. Wartmann, M., D. Campbell, A. Subramanian, S. Burstein, and R. J. Davis. 1995. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett. 359:133.
58. Pestonjamasp, V. K., and S. H. Burstein. 1998. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim. Biophys. Acta 1394:249.
59. 2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186:1603.